Literature DB >> 22548802

Detection of Transglutaminase 2 conformational changes in living cell.

Marat S Pavlyukov1, Nadezhda V Antipova, Maria V Balashova, Mikhail I Shakhparonov.   

Abstract

Transglutaminase 2 (TG2) is a ubiquitous Ca(2+)-dependent protein cross-linking enzyme that is implicated in a variety of biological disorders. In in vitro experiments when Ca(2+) concentration was increased TG2 changed its conformation and was able to cross-link other proteins via formation of an isopeptide bond. However the mechanisms that regulate TG2 transamidation activity in cells are still unknown. In this study we have developed FRET-based method for monitoring TG2 conformation changes and, probably, cross-linking activity in living cells. Using this approach we have showed that a significant amount of TG2 within the cell is accumulated in perinuclear endosomes and has a cross-linking inactive conformation, while TG2 that is located beneath the cell membrane has a transamidation active conformation. After the induction of apoptosis cytoplasmic TG2 changed its conformation and activates while, TG2 in endosomes retained transamidation inactive conformation even at late stages of apoptosis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22548802     DOI: 10.1016/j.bbrc.2012.04.082

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

2.  Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity.

Authors:  Ellen A Rorke; Gautam Adhikary; Henryk Szmacinski; Joseph R Lakowicz; David J Weber; Raquel Godoy-Ruiz; Purushottamachar Puranik; Jeffrey W Keillor; Eric W J Gates; Richard L Eckert
Journal:  Mol Carcinog       Date:  2021-10-05       Impact factor: 4.784

3.  Naturally Occurring Epsilon Gamma Glutamyl Lysine Isopeptide Crosslinks in Human Neuroblastoma SH-SY5Y Cells.

Authors:  Oksana Lockridge; Lawrence M Schopfer
Journal:  ACS Omega       Date:  2022-06-16

4.  Multi-Omics Analysis of Glioblastoma and Glioblastoma Cell Line: Molecular Insights Into the Functional Role of GPR56 and TG2 in Mesenchymal Transition.

Authors:  Raksha A Ganesh; Pranali Sonpatki; Divya Naik; Arivusudar Everad John; Gajanan Sathe; Akhila Lakshmikantha; Komal Prasad Chandrachari; Lea Bauer; Vera Knäuper; Daniel Aeschlimann; Krishnan Venkatraaman; Nameeta Shah; Ravi Sirdeshmukh
Journal:  Front Oncol       Date:  2022-05-03       Impact factor: 5.738

5.  Transglutaminase in Receptor and Neurotransmitter-Regulated Functions.

Authors:  Nancy A Muma
Journal:  Med One       Date:  2018-12-05

Review 6.  Transglutaminase is a tumor cell and cancer stem cell survival factor.

Authors:  Richard L Eckert; Matthew L Fisher; Dan Grun; Gautam Adhikary; Wen Xu; Candace Kerr
Journal:  Mol Carcinog       Date:  2015-08-10       Impact factor: 4.784

7.  Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.

Authors:  Marat S Pavlyukov; Hai Yu; Soniya Bastola; Mutsuko Minata; Victoria O Shender; Yeri Lee; Suojun Zhang; Jia Wang; Svetlana Komarova; Jun Wang; Shinobu Yamaguchi; Heba Allah Alsheikh; Junfeng Shi; Dongquan Chen; Ahmed Mohyeldin; Sung-Hak Kim; Yong Jae Shin; Ksenia Anufrieva; Evgeniy G Evtushenko; Nadezhda V Antipova; Georgij P Arapidi; Vadim Govorun; Nikolay B Pestov; Mikhail I Shakhparonov; L James Lee; Do-Hyun Nam; Ichiro Nakano
Journal:  Cancer Cell       Date:  2018-06-21       Impact factor: 31.743

8.  The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells.

Authors:  Julia Aepler; Johanna Wodtke; Robert Wodtke; Cathleen Haase-Kohn; Reik Löser; Jens Pietzsch; Sandra Hauser
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

9.  Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.

Authors:  C Kerr; H Szmacinski; M L Fisher; B Nance; J R Lakowicz; A Akbar; J W Keillor; T Lok Wong; R Godoy-Ruiz; E A Toth; D J Weber; R L Eckert
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.